How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/prevention-of-recurrent-venous-thrombosis-associated-with-malignancy.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Prevention of Recurrent Venous Thrombosis Associated with Malignancy — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Prevention of Recurrent Venous Thrombosis Associated with Malignancy (disease) competitive landscape: 2 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

2 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Prevention of Recurrent Venous Thrombosis Associated with Malignancy, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	Line of therapy	First approval
Heparin Sodium In Plastic Container	HEPARIN	Merck & Co.	Anti-coagulant	Antithrombin-III		1939-01-01
Heparin Sodium In Plastic Container	Heparin Sodium	Fresenius Kabi	Anticoagulant	Antithrombin III, Coagulation Factors Xa and IIa		1939-01-01

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Fresenius Kabi · 1 drug in Prevention of Recurrent Venous Thrombosis Associated with Malignancy
Merck & Co. · 1 drug in Prevention of Recurrent Venous Thrombosis Associated with Malignancy

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Prevention of Recurrent Venous Thrombosis Associated with Malignancy:

Cite this brief

Drug Landscape (2026). Prevention of Recurrent Venous Thrombosis Associated with Malignancy — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/prevention-of-recurrent-venous-thrombosis-associated-with-malignancy. Accessed 2026-06-10.

Prevention of Recurrent Venous Thrombosis Associated with Malignancy full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing